<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="1" total-samples="36" total-assays="36"><experiment><id>525686</id><accession>E-GEOD-9599</accession><secondaryaccession>GSE9599</secondaryaccession><name>Transcription profiling by array of human pancreatic cancers resistant to EGFR inhibition</name><releasedate>2008-06-16</releasedate><lastupdatedate>2015-07-29</lastupdatedate><organism>Homo sapiens</organism><experimenttype>transcription profiling by array</experimenttype><experimentdesign>unknown experiment type</experimentdesign><description><id/><text>Tumors from pancreatic cancer specimens obtained at surgery were used for efficacy testing and biologic analysis Experiment Overall Design: Eighteen tumor samples were profiled in duplicates.  Ten samples were used in the training set and eight samples were used as the validation set.</text></description><provider><contact>Aik Choon Tan</contact><role>submitter</role><email>actan@jhu.edu</email></provider><bibliography><accession>18413752</accession><authors>Jimeno A, Tan AC, Coffa J, Rajeshkumar NV, Kulesza P, Rubio-Viqueira B, Wheelhouse J, Diosdado B, Messersmith WA, Iacobuzio-Donahue C, Maitra A, Varella-Garcia M, Hirsch FR, Meijer GA, Hidalgo M</authors><title>Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.</title><status>published</status></bibliography><samplecharacteristic><category>cell type</category><value>tumor</value></samplecharacteristic><samplecharacteristic><category>clinical information</category><value>mouse xenograft</value></samplecharacteristic><samplecharacteristic><category>disease</category><value>pancreatic cancer</value></samplecharacteristic><samplecharacteristic><category>organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>pancreas</value></samplecharacteristic><samplecharacteristic><category>phenotype</category><value>EGFR inhibition resistant</value><value>EGFR inhibition sensitive</value></samplecharacteristic><experimentalvariable><name>phenotype</name><value>EGFR inhibition resistant</value><value>EGFR inhibition sensitive</value></experimentalvariable><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>36</count><legacy_id>405156763</legacy_id></arraydesign><protocol><id>1143891</id><accession>P-G9599-2</accession></protocol><protocol><id>62</id><accession>Affymetrix:Protocol:Hybridization-Unknown</accession></protocol><protocol><id>1143890</id><accession>P-G9599-1</accession></protocol><protocol><id>51</id><accession>P-AFFY-6</accession></protocol><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>36</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>36</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>36</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>36</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>processedDataMatrix</dataformat><bioassays>1</bioassays><isderived>1</isderived></bioassaydatagroup></experiment></experiments>